BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10920275)

  • 1. Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship.
    Mutoh M; Takahashi M; Fukuda K; Komatsu H; Enya T; Matsushima-Hibiya Y; Mutoh H; Sugimura T; Wakabayashi K
    Jpn J Cancer Res; 2000 Jul; 91(7):686-91. PubMed ID: 10920275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure.
    Mutoh M; Takahashi M; Fukuda K; Matsushima-Hibiya Y; Mutoh H; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 May; 21(5):959-63. PubMed ID: 10783318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells.
    Fukuda K; Hibiya Y; Mutoh M; Koshiji M; Akao S; Fujiwara H
    J Ethnopharmacol; 1999 Aug; 66(2):227-33. PubMed ID: 10433483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription.
    O'Leary KA; de Pascual-Teresa S; Needs PW; Bao YP; O'Brien NM; Williamson G
    Mutat Res; 2004 Jul; 551(1-2):245-54. PubMed ID: 15225597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells.
    Glinghammar B; Rafter J
    Gastroenterology; 2001 Feb; 120(2):401-10. PubMed ID: 11159881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase active bioflavonoids from Balaton tart cherry and their structure activity relationships.
    Wang H; Nair MG; Strasburg GM; Booren AM; Gray I; Dewitt DL
    Phytomedicine; 2000 Mar; 7(1):15-9. PubMed ID: 10782485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells.
    Inoue H; Tanabe T
    Biochem Biophys Res Commun; 1998 Mar; 244(1):143-8. PubMed ID: 9514889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAR: flavonoids and COX-2 inhibition.
    Rosenkranz HS; Thampatty BP
    Oncol Res; 2003; 13(12):529-35. PubMed ID: 12899243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of c-Jun induction and coactivator p300 in epidermal growth factor-induced gene expression of cyclooxygenase-2 in human epidermoid carcinoma A431 cells.
    Chen LC; Chen BK; Chang JM; Chang WC
    Biochim Biophys Acta; 2004 Jul; 1683(1-3):38-48. PubMed ID: 15238218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells.
    Inoue H; Umesono K; Nishimori T; Hirata Y; Tanabe T
    Biochem Biophys Res Commun; 1999 Jan; 254(2):292-8. PubMed ID: 9918831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses of ferulic acid derivatives and their suppressive effects on cyclooxygenase-2 promoter activity.
    Hosoda A; Ozaki Y; Kashiwada A; Mutoh M; Wakabayashi K; Mizuno K; Nomura E; Taniguchi H
    Bioorg Med Chem; 2002 Apr; 10(4):1189-96. PubMed ID: 11836130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15.
    Saikawa Y; Sugiura T; Toriumi F; Kubota T; Suganuma K; Isshiki S; Otani Y; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(5A):2723-8. PubMed ID: 15517878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways.
    Liu W; Reinmuth N; Stoeltzing O; Parikh AA; Tellez C; Williams S; Jung YD; Fan F; Takeda A; Akagi M; Bar-Eli M; Gallick GE; Ellis LM
    Cancer Res; 2003 Jul; 63(13):3632-6. PubMed ID: 12839952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
    Liu CY; Lai YY; Lo CJ
    J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains.
    Zhu Y; Hua P; Lance P
    Cancer Res; 2003 Jan; 63(2):522-6. PubMed ID: 12543811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
    Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
    Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; IƱiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.